These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2510435)

  • 41. Peripheral neuropathy and haemolytic anaemia with cherry red spot on macula in dapsone poisoning.
    Abhayambika K; Chacko A; Mahadevan K; Najeeb OM
    J Assoc Physicians India; 1990 Aug; 38(8):564-5. PubMed ID: 2174032
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Agranulocytosis caused by dapsone in rheumatoid arthritis].
    Eulry F; Pattin S; Auzanneau G; Martoia R; Doury P
    Ann Med Interne (Paris); 1989; 140(1):55-6. PubMed ID: 2735638
    [No Abstract]   [Full Text] [Related]  

  • 43. Asymptomatic dapsone-induced agranulocytosis in a patient with chronic spontaneous urticaria.
    Milkova L; Hallermann C; Simon JC; Treudler R
    J Dtsch Dermatol Ges; 2014 Aug; 12(8):717-9. PubMed ID: 24981604
    [No Abstract]   [Full Text] [Related]  

  • 44. Full dapsone dose made possible by control of anaemia with darbepoetin-alpha.
    Flosadóttir E; Bjarnason B
    Acta Derm Venereol; 2008; 88(5):540-1. PubMed ID: 18779910
    [No Abstract]   [Full Text] [Related]  

  • 45. Aspirin-induced acute haemolytic anaemia in glucose-6-phosphate dehydrogenase-deficient children with systemic arthritis.
    Meloni T; Forteleoni G; Ogana A; Franca V
    Acta Haematol; 1989; 81(4):208-9. PubMed ID: 2502894
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Commentary to a paper by Flosadóttir & Bjarnason on full dapsone dose made possible by control of anaemia with darbepoetin-alpha.
    Mobacken H
    Acta Derm Venereol; 2008; 88(6):639. PubMed ID: 19002361
    [No Abstract]   [Full Text] [Related]  

  • 47. The antimalarial and hemolytic properties of 4,4-diaminodiphenyl sulfone (DDS).
    Powell RD; DeGowin RL; Eppes RB; McNamara JV; Carson PE
    Int J Lepr Other Mycobact Dis; 1967; 35(4):590-604. PubMed ID: 4869693
    [No Abstract]   [Full Text] [Related]  

  • 48. Agranulocytosis during dapsone administration.
    Ten Broeke JE; Cunningham LD
    Dermatologica; 1973; 146(1):21-4. PubMed ID: 4694139
    [No Abstract]   [Full Text] [Related]  

  • 49. Dapsone-induced agranulocytosis: spontaneous reporting data.
    Cockburn EM; Wood SM; Waller PC; Bleehen SS
    Br J Dermatol; 1993 Jun; 128(6):702-3. PubMed ID: 8338759
    [No Abstract]   [Full Text] [Related]  

  • 50. Dapsone-Induced Hemolytic Anemia in Multiple Myeloma: Case Report of Various Differential Diagnoses.
    Rassner M; Jung J; Schneider J; Wäsch R; Engelhardt M
    Clin Lymphoma Myeloma Leuk; 2020 Nov; 20(11):e821-e825. PubMed ID: 32753123
    [No Abstract]   [Full Text] [Related]  

  • 51. Drug-induced blood dyscrasias in Sweden.
    Böttiger LE; Westerholm B
    Br Med J; 1973 Aug; 3(5875):339-43. PubMed ID: 4723818
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dapsone hypersensitivity syndrome not related to G6PD deficiency.
    Schulkes KJ; Tervaert JW; Rijken F; Haas LE
    BMJ Case Rep; 2015 Dec; 2015():. PubMed ID: 26682839
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acne fulminans with dapsone induced haemolysis: a case report.
    Ismail R
    Med J Malaysia; 1987 Jun; 42(2):124-6. PubMed ID: 2971861
    [No Abstract]   [Full Text] [Related]  

  • 54. Hematologic safety of dapsone gel, 5%, for topical treatment of acne vulgaris.
    Piette WW; Taylor S; Pariser D; Jarratt M; Sheth P; Wilson D
    Arch Dermatol; 2008 Dec; 144(12):1564-70. PubMed ID: 19075138
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High dose dapsone toxicity.
    Shelley WB; Goldwein MI
    Br J Dermatol; 1976 Jul; 95(1):79-82. PubMed ID: 952745
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dapsone-induced hemolytic anemia.
    Jollow DJ; Bradshaw TP; McMillan DC
    Drug Metab Rev; 1995; 27(1-2):107-24. PubMed ID: 7641572
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drug induced acute haemolytic anaemia in glucose-6-phosphate dehydrogenase deficiency subjects.
    Rajkondawar VL; Modi TH; Mishra SN
    J Assoc Physicians India; 1968 Sep; 16(9):589-93. PubMed ID: 5711919
    [No Abstract]   [Full Text] [Related]  

  • 58. Fatal dapsone agranulocytosis in a Melanesian.
    Barss P
    Lepr Rev; 1986 Mar; 57(1):63-6. PubMed ID: 3702582
    [No Abstract]   [Full Text] [Related]  

  • 59. Why agranulocytosis from dapsone?
    Jopling WH
    Ann Intern Med; 1972 Jul; 77(1):153. PubMed ID: 5052443
    [No Abstract]   [Full Text] [Related]  

  • 60. Frequency of glucose 6 phosphate dehydrogenase deficiency and related hemolytic anemia in Riyadh, Saudi Arabia.
    Gandapur AS; Qureshi F; Mustafa G; Baksh S; Ramzan M; Khan MA
    J Ayub Med Coll Abbottabad; 2002; 14(3):24-6. PubMed ID: 12476860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.